More with less through new global commercial operating model
The why
The challenge
The commercial model was highly decentralised, with significant affiliate autonomy and limited global brand leadership. Brand planning, campaign execution, and local activation were often managed in parallel rather than through a shared model.
At the same time, budgets were too heavy relative to current revenue, portfolio maturity, and pipeline, despite more launches expected in the near term. Functional silos added to the challenge, with global, regional, franchise, and affiliate teams often working independently.
How we helped
We helped define the target operating model across affiliate archetyping, global-to-local strategy, ways of working, and brand processes, creating a more standardised and efficient model for commercial execution.
Outcome

What moved the needle
Daniel Schmidt
Daniel works with life science executives to design strategies, operating models, and transformation programs. He brings both functional depth and board-level perspectives, helping senior leaders navigate complexity and make clear choices. He formerly led the life science practice at Deloitte Denmark.
Daniel holds a B.Sc. in International Business and an M.Sc. in Economics and Business Administration from Copenhagen Business School.
- TA strategy for immunology portfolio
- Strategy for application and value realisation of AI across R&D
- Business model design for new innovative business unit
- Global digital transformation across commercial functions